|1.||Samochowiec, Agnieszka: 3 articles (10/2014 - 01/2012)|
|2.||Tybura, Piotr: 3 articles (10/2014 - 01/2012)|
|3.||Grzywacz, Anna: 3 articles (10/2014 - 01/2012)|
|4.||Samochowiec, Jerzy: 3 articles (10/2014 - 01/2012)|
|5.||Leucht, Stefan: 2 articles (01/2015 - 01/2014)|
|6.||Beszlej, Aleksander: 2 articles (10/2014 - 01/2012)|
|7.||Frydecka, Dorota: 2 articles (10/2014 - 01/2012)|
|8.||Mak, Monika: 2 articles (07/2013 - 01/2012)|
|9.||Kiejna, Andrzej: 2 articles (11/2012 - 05/2010)|
|10.||Leucht, S: 2 articles (01/2006 - 01/2002)|
|1.||Schizophrenia (Dementia Praecox)
11/01/1988 - "Predictors of neuroleptic treatment response in acute schizophrenia: results of a treatment study with perazine."
01/01/2014 - "Perazine for schizophrenia."
01/01/2006 - "Perazine for schizophrenia."
01/01/2002 - "Perazine for schizophrenia."
01/01/1992 - "The ratio between desmethyl-perazine and perazine was not predictive of (non-) response to neuroleptic treatment in schizophrenia."
|2.||Psychotic Disorders (Schizoaffective Disorder)
05/01/2010 - "[Perazine in the treatment of psychotic disorders--research review]."
01/01/1993 - "10 patients suffering from reactive psychoses were treated in a standardized manner with pernazine. "
06/20/1960 - "[Indications for perazin (taxilan) and the psycho-pathology of its effect in endogenous psychoses]."
01/01/2014 - "We selected all randomised controlled trials that compared perazine with other treatments for people with schizophrenia or schizophrenia-like psychoses, or both. "
01/01/2006 - "We selected all randomised controlled trials that compared perazine with other treatments for people with schizophrenia and/or schizophrenia-like psychoses. "
|3.||Paranoid Schizophrenia (Delusional Disorder)
07/01/1989 - "The group of 16 patients with paranoid schizophrenia, chosen in careful diagnostic procedure was treated with perazine during 4 weeks time. "
09/01/1991 - "[Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness]."
01/01/1989 - "[Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia]."
01/01/1989 - "In order to evaluate the influence of some neuroleptics on unproductive symptoms of schizophrenic process, first hospitalized patients with paranoid schizophrenia underwent monotherapy with perazine, fluphenazine, trifluoroperazine, chlorpromazine, and haloperidol. "
|4.||Body Weight (Weight, Body)
04/01/2000 - "In this trial, 136 hospitalized patients met the ICD-10 criteria for acute manic episodes; these patients received a fixed dose of 20 mg/kg of body weight of sodium valproate (Orfiril, Desitin Arzneimittel GmbH, Hamburg, Germany) orally, in addition to basic neuroleptic medication, preferably haloperidol and/or perazine. "
|5.||Mental Disorders (Mental Disorder)
11/01/2012 - "[Physicians' opinion on the use of perazine in the treatment of mental disorders--results of the Delphi consensus study]."
11/01/2012 - "According to clinicians pernazine is a safe and versatile medication for schizophrenia or other mental disorders and serves as the alternative for SGA."
|3.||Antipsychotic Agents (Antipsychotics)
|10.||Valproic Acid (Valproate, Semisodium)